Molecular genetics of testicular cancer: What does the clinician need to know?

Actionable targets in patients with cisplatin-resistant advanced germ cell tumours

The DNA damage response

From genotype to molecular phenotype by proteomics

TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy

Editor's choice for December 2015

Novel estrogen receptor-targeting agent represents ‘quantum leap’

ASH 2015: Latest in CLL

How can functional drug screening guide personalised cancer therapy?

Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia

First targeted therapy for multiple myeloma effective against hard-to-treat disease

First targeted therapy for genetically defined subset with acute myeloid leukaemia significantly improves survival